Bank Of New York Mellon Corp Praxis Precision Medicines, Inc. Transaction History

Bank Of New York Mellon Corp

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$1.88 - $2.49 $223,325 - $295,787	118,790 New	118,790 $282,000
Q3 2022 Nov 14, 2022	BUY	$2.5 - $4.77 $37,615 - $71,769	15,046 Added 14.5%	118,790 $269,000
Q2 2022 Aug 15, 2022	SELL	$1.75 - $11.34 $10,111 - $65,522	-5,778 Reduced 5.28%	103,744 $254,000
Q1 2022 May 11, 2022	BUY	$10.21 - $20.29 $19,807 - $39,362	1,940 Added 1.8%	109,522 $1.12 Million
Q4 2021 Feb 11, 2022	BUY	$16.76 - $22.99 $66,939 - $91,822	3,994 Added 3.86%	107,582 $2.12 Million

Q3 2021 Nov 12, 2021	BUY	$13.15 - $22.56 $455,739 - $781,861	34,657 Added 50.28%	103,588 $1.92 Million
Q2 2021 Aug 11, 2021	BUY	$18.28 - $33.05 $652,285 - $1.18 Million	35,683 Added 107.32%	68,931 $1.26 Million
Q1 2021 May 13, 2021	BUY	$29.34 - $60.2 $105,037 - $215,516	3,580 Added 12.07%	33,248 $1.09 Million
Q4 2020 Feb 09, 2021	BUY	$27.25 - $55.82 $808,453 - $1.66 Million	29,668 New	29,668 $1.63 Million

75K

Ticker PRAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,576,100
Market Cap $1.84B
Description
Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, develops therapies for central nervous system disorders characterized by neuronal imbalance. Its lead product candidates include PRAX-114, an extrasynaptic-preferring GABAA receptor positive allosteric modulator that is in Phase IIa clinical trial for the treatment of ...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.